Clinical Research Directory
Browse clinical research sites, groups, and studies.
Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers
Sponsor: British University In Egypt
Summary
The goal of this observational study is to learn whether two inflammatory proteins, interleukin-8 (IL-8) measured in saliva and interleukin-6 (IL-6) measured in blood serum, can help distinguish adults with oral potentially malignant disorders (OPMDs), such as oral lichen planus and leukoplakia, from adults with healthy oral mucosa, and whether smoking changes these protein levels. The main questions it aims to answer are: * Do salivary IL-8 and serum IL-6 levels differ between people with OPMDs and healthy controls, and does this difference depend on smoking status? * How well do IL-8 and IL-6, alone or combined, discriminate people with OPMDs from healthy controls? Researchers compared healthy never-smokers, healthy current smokers, never-smokers with OPMDs, and current smokers with OPMDs. An additional exploratory group of current smokers with oral squamous cell carcinoma (OSCC) was compared with current smokers with OPMDs. Participants provided an unstimulated whole saliva sample and a blood sample at a single visit, and completed a clinical, periodontal, and tobacco-use assessment. No treatment was assigned as part of the study.
Official title: Diagnostic Performance of Salivary Interleukin-8 and Serum Interleukin-6 for Oral Potentially Malignant Disorders: Effect Modification by Smoking Status - A Cross-Sectional Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2026-10-01
Completion Date
2027-01-30
Last Updated
2026-11-04
Healthy Volunteers
Yes
Conditions
Interventions
Salivary IL-8 and Serum IL-6 Measurement
No treatment is assigned. All participants provide a single unstimulated whole saliva sample, analyzed for interleukin-8 (IL-8), and a blood sample, from which serum is analyzed for interleukin-6 (IL-6). Concentrations are measured by immunoassay and expressed in pg/mL. Biomarker levels are compared between groups and evaluated, individually and combined, for diagnostic discrimination.
Locations (1)
The British University in Egypt
Cairo, Egypt